shutterstock_723369586_phushutter
Phushutter / Shutterstock.com
23 April 2019Big Pharma

Hologics and Grifols agree $14m Enzo settlement

Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and  Grifols, ending a patent dispute between the parties.

In a  filing to the  US Securities and Exchange Commission on April 16, Enzo said it would receive one-off payments from the companies in exchange for worldwide licences.

Under the terms of the agreement,  Hologic will pay Enzo $10.5 million and Grifols will pay $3.5 million.

The patents in dispute were (US numbers 6,992,180; 7,064,197; 6,221,581) and cover modified nucleotides that are used in diagnostic and therapeutic applications.

In its filing, Enzo said the agreement should not be considered an admission of liability or responsibility, or lack thereof, on the part of Enzo, Hologic or Grifols.

The news comes four years after Enzo filed 12 patent suits against various companies for infringing multiple patents. Since then, it has entered into licensing agreements with many companies.

In January,  Roche agreed to pay Enzo $21 million to settle a patent infringement case between the two companies.

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.
Americas
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.

More on this story

Big Pharma
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.
Americas
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.

More on this story

Big Pharma
2 February 2021   A decision by the Supreme Court over the assignor estoppel doctrine could have far-reaching implications for patent law, argue Jeffrey D Morton, Zachary Schroeder and Ryan D Ricks of Snell & Wilmer.
Americas
12 March 2020   The University of South Florida Research Foundation has accused medical technology company Hologic of patent infringement, related to diagnosis methods for digital mammography.
Americas
13 May 2020   The US Supreme Court should not take up a petition asking whether it’s a violation of the Fifth Amendment for patents issued before the enactment of the American Invents Act to be subjected to inter partes reviews, according to the US government.